Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has announced the launch of the GLP-1 Health Check—a set of comprehensive packages with up to 81 tests designed to monitor vital health parameters before, during and after GLP-1 therapy. Priced from ₹2,799 and available across India, these packages aim to empower individuals and clinicians with accurate diagnostic insights at every stage of treatment.
Glucagon-Like Peptide-1 (GLP-1) is a natural hormone that helps regulate blood sugar levels, control appetite, and slow digestion. Medications known as GLP-1 agonists mimic this hormone and are increasingly being prescribed for the management of obesity and type 2 diabetes. Their growing popularity for weight loss has drawn both public interest and medical caution, with doctors emphasising the need for continuous monitoring to ensure treatment safety and effectiveness.
The GLP-1 packages from Thyrocare have been developed to help individuals establish their health baseline before starting therapy and to track their progress as treatment continues. Regular monitoring enables early detection of side effects, nutritional deficiencies, and changes in key metabolic functions, ensuring that patients can use these therapies safely under medical guidance.
People with obesity and/or diabetes type 2 generally have insulin resistance, high blood sugars, cholesterol derangement, fatty liver and increased risk of heart disease. Keeping this in mind, Thyrocare has curated GLP-1 packages in partnership with leading doctors in the field.
These packages are designed to monitor lipid profile, fasting blood glucose, insulin fasting, HOMA insulin resistance index, liver function test and cardiac risk markers to see how well the medication is working. It is also recommended to check for kidney function before starting and during GLP-1 therapy to establish a baseline and rule out any side effects like dehydration or electrolyte imbalances. Some potential side effects require close monitoring - GLP-1 medicines substantially reduce appetite, which can result in nutritional deficiencies or anemia over time. Regular testing of vitamin D, vitamin B12 and hemoglobin levels helps ensure nutritional balance and overall well-being. In some cases GLP-1 therapy can cause pancreatitis and thyroid disorders. These packages therefore also include assessments for pancreatic health (amylase, lipase) and thyroid function (T3, T4, TSH).
All of these tests are included in a single package by Thyrocare, making comprehensive testing available while undergoing GLP-1 therapy.
Commenting on the launch, Rahul Guha, MD & CEO, Thyrocare Technologies Ltd, said, “As GLP-1-based medicines become more widely used in India for weight management and diabetes, it’s important to accompany this trend with reliable diagnostic support. These therapies are powerful and effective when used responsibly, but they work best when combined with consistent monitoring. With this package, our goal is to make that process easier and more accessible for people across the country.”
With its ability to map health trends and treatment progress over time, Thyrocare empowers individuals and clinicians with actionable insights for sustained, safe, and informed use of GLP-1 therapies.
Dr. Shehla Shaikh, MD (General Medicine), DM (Endocrinology), consulting endocrinologist at leading hospitals, emphasised, “As obesity emerges as a global health challenge, it is essential to pair weight-management GLP-1 therapy with structured medical monitoring, beginning with baseline screening and continuing with periodic reviews. These treatments are highly effective when supervised, and comprehensive testing helps ensure nutritional balance, organ health, and long-term safety.”
These packages can be booked through Thyrocare, Pharmeasy and all partners. By making comprehensive metabolic testing available at an affordable price, Thyrocare continues to support preventive and precision healthcare for a growing number of Indians looking to manage their health proactively — whether for diabetes, obesity, or overall metabolic wellness.
